Showing 11,641 - 11,660 results of 24,808 for search '(( 50 ((ng decrease) OR (mean decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 11641

    Thyroxine Differentially Modulates the Peripheral Clock: Lessons from the Human Hair Follicle by Jonathan A. Hardman (714625)

    Published 2015
    “…Over 24 hours we found a significant reduction in protein levels of BMAL1 and PER1, with their transcript levels also decreasing significantly. …”
  2. 11642

    Descriptive and inferential analysis. by Júlio A. Costa (13172340)

    Published 2025
    “…They were similar in age (61.6 ± 8.6 and 60.8 ± 6.9, respectively). Males covered a higher distance per minute than females, with sex showing a moderate effect (63.3 ± 10.7 m/min vs. 54.7 ± 15.8 m/min; p < .001; Cohen’s <i>d</i><sub><i>unbiased</i></sub> = 0.69 [0.36; 1.03]), especially in fast walking (41.7 ± 12.2 m/min vs. 32.6 ± 16.7 m/min; p < .001; Cohen’s <i>d</i><sub><i>unbiased</i></sub> = 0.66 [0.33; 1.00]). …”
  3. 11643

    Regulation of the E(spl)-C and <i>invected-engrailed</i> complex by cohesin and Nipped-B. by Cheri A. Schaaf (144616)

    Published 2009
    “…Nipped-B knockdown shows similar time courses in Nipped-B protein and E(spl)-C and <i>invected-engrailed</i> transcripts (not shown), except that some E(spl)-C transcripts decrease on day 3 (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0006202#pone-0006202-g003" target="_blank">Figure 3</a>). …”
  4. 11644

    Data Sheet 1_Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatment.pdf by Alice A. White (21695726)

    Published 2025
    “…Differences in the abundance of other T cell subsets were detected in both trans males and trans females, however only a decrease in CD161<sup>+</sup> T effector memory cells in trans males, compared to control females, was associated with lower testosterone levels. …”
  5. 11645

    Table_1_Effectiveness of sofosbuvir-based treatments for patients with hepatitis C virus genotype 6 infection: a real-world study from East China.DOC by Fan-Rong Jiang (20325720)

    Published 2024
    “…In PP population, the end of treatment virological response rate was 99.48% (190/191), the SVR12 rate was 99.31% (143/144), and the SVR24 rate was 100.00% (75/75). Only one patient with genotype 6a experienced a relapse 12 weeks after the completion of treatment, but her HCV RNA was undetectable both at the end of treatment and 24 weeks after the end of treatment. …”
  6. 11646

    Table 1_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  7. 11647

    Table 3_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  8. 11648

    Table 2_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  9. 11649
  10. 11650

    Data Sheet 1_Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.zip by Peixi Zhao (620068)

    Published 2025
    “…</p>Methods<p>Using data from the GBD 2021 data, we conducted a secondary analysis. We assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of MS across 204 countries/territories from 1990 to 2021, calculating age-standardized rates.…”
  11. 11651

    Data Sheet 2_Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.docx by Peixi Zhao (620068)

    Published 2025
    “…</p>Methods<p>Using data from the GBD 2021 data, we conducted a secondary analysis. We assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of MS across 204 countries/territories from 1990 to 2021, calculating age-standardized rates.…”
  12. 11652
  13. 11653
  14. 11654

    Supplementary Material for: A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status that respo... by Egusa H. (19645753)

    Published 2024
    “…She had fever and her PS was 3, and her CRP was 6.47 mg/dL due to inflammation by a G-CSF-producing tumor. Thus, we initiated the administration of dexamethasone (3.3 mg/day). …”
  15. 11655

    Table_1_Association of Yogurt and Dietary Supplements Containing Probiotic Consumption With All-Cause and Cause-Specific Mortality in US Adults: A Population-Based Cohort Study.XLS by Ping Lin (146330)

    Published 2022
    “…</p>Methods<p>We conducted an observational cohort study comprised of a nationally representative sample of adults who were enrolled in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2014. …”
  16. 11656

    DataSheet1_Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron.PDF by A. E. Muderrisoglu (19204042)

    Published 2024
    “…Decreases were resistant to the β<sub>3</sub>-AR antagonist L-748,337 (0.34–0.55 fold, 100–150 nM, 20 h). …”
  17. 11657

    Risk of Urogenital Infections in People with Type 2 Diabetes Initiating SGLT2i versus GLP-1RA in Routine Clinical Care: A Danish Cohort Study by Christine Ljungberg (20880865)

    Published 2025
    “…</p><p><br></p><p dir="ltr">Results </p><p dir="ltr">This study included 52,414 SGLT2i initiators and 27,023 GLP-1RA initiators with a median follow-up of 2.9 to 3.9 years. The estimated risks of UTI within the first year were nearly identical: 10.0% in SGLT2is, 10.2% in GLP-1RAs in intention-to-treat analyses corresponding to a risk ratio of 0.98 (95% CI 0.94, 1.03). …”
  18. 11658

    Table 2_Soybean yield, nutrient use efficiency, and economic returns of phosphorus and potassium in Ghana’s interior savanna.docx by George A. Awuni (14632778)

    Published 2024
    “…</p>Materials and methods<p>The treatments were 4 × 4 factorial combinations of P at 0, 25, 50, and 100 P<sub>2</sub>O<sub>5</sub> (kg ha<sup>−1</sup>) and K at 0, 25, 50, and 100 K<sub>2</sub>O (kg ha<sup>−1</sup>), and their combinations laid out in a randomized complete block design with four replications. …”
  19. 11659

    Table 5_Soybean yield, nutrient use efficiency, and economic returns of phosphorus and potassium in Ghana’s interior savanna.docx by George A. Awuni (14632778)

    Published 2024
    “…</p>Materials and methods<p>The treatments were 4 × 4 factorial combinations of P at 0, 25, 50, and 100 P<sub>2</sub>O<sub>5</sub> (kg ha<sup>−1</sup>) and K at 0, 25, 50, and 100 K<sub>2</sub>O (kg ha<sup>−1</sup>), and their combinations laid out in a randomized complete block design with four replications. …”
  20. 11660

    Table 7_Soybean yield, nutrient use efficiency, and economic returns of phosphorus and potassium in Ghana’s interior savanna.docx by George A. Awuni (14632778)

    Published 2024
    “…</p>Materials and methods<p>The treatments were 4 × 4 factorial combinations of P at 0, 25, 50, and 100 P<sub>2</sub>O<sub>5</sub> (kg ha<sup>−1</sup>) and K at 0, 25, 50, and 100 K<sub>2</sub>O (kg ha<sup>−1</sup>), and their combinations laid out in a randomized complete block design with four replications. …”